Table 1.
Age-standardized prevalence rates of nonalcoholic fatty liver disease in patients aged 65–89 years in 2010 and 2019 in Western Pacific and Southeast Asia, stratified by sex.
| 2010 Prevalence (95% UI) |
2010 ASPR, per 100,000 (95% UI) |
2019 Prevalence (95% UI) |
2019 ASPR, per 100,000 (95% UI) |
APC (95% CI) |
p | |
|---|---|---|---|---|---|---|
| Western Pacific | ||||||
| Overall | 50,872,617.88 (42,425,025.12 to 60,674,143.65) |
30,171.62 (25,161.51 to 35,984.73) |
78,901,129.54 (66,357,352.99 to 92,968,439.78) |
32,821.78 (27,603.74 to 38,673.58) |
0.95 (0.87 to 1.03) |
<0.001 |
| Female | 26,989,633.59 (22,468,540.21 to 32,562,717.23) |
30,017.44 (24,989.15 to 36,215.73) |
40,095,703.93 (33,317,904.88 to 48,768,977.91) |
31,247.77 (25,965.63 to 38,007.11) |
0.59 (0.35 to 0.83) |
<0.001 |
| Male | 23,882,984.29 (19,905,539.39 to 28,371,702.26) |
30,347.79 (25,293.7 to 36,051.54) |
38,805,425.61 (32,892,635.6 to 45,127,982.77) |
34,623.83 (29,348.19 to 40,265.09) |
1.3 (1.12 to 1.48) |
<0.001 |
| Southeast Asia | ||||||
| Overall | 33,306,919.91 (27,504,062.2 to 40,512,069.6) |
34,295.03 (28,320.02 to 41,713.93) |
50,406,719.89 (41,956,546.18 to 60,400,342.45) |
36,995.37 (30,793.47 to 44,330.06) |
0.87 (0.78 to 0.95) |
<0.001 |
| Female | 16,388,617.1 (13,407,026.03 to 20,105,405.24) |
31,935.36 (26,125.34 to 39,178.01) |
25,081,401.08 (20,780,159.13 to 30,536,791.54) |
34,912.59 (28,925.38 to 42,506.33) |
1.01 (0.9 to 1.11) |
<0.001 |
| Male | 16,918,302.81 (14,079,388.13 to 20,414,306.75) |
36,938.96 (30,740.55 to 44,572.04) |
25,325,318.8 (21,207,566.73 to 30,006,548.71) |
39,318.41 (32,925.46 to 46,586.17) |
0.68 (0.57 to 0.79) |
<0.001 |
Abbreviations: ASPR—age-standardized prevalence rates; APC—annual percentage change; CI—confidence interval; UI—uncertainty interval.